MeSH tree: G06.920
For adults with mild-to-moderate COVID-19, early administration of simnotrelvir plus ritonavir shortens the time to sustained resolution of symptoms, according to a study published in the Jan. 18 issue of the New England ...
Jan 18, 2024
0
29
A novel device developed by researchers from Tokyo Institute of Technology, Tokyo Medical and Dental University, and Chiba University in a new study utilizes ions and an electric field to effectively capture infectious droplets ...
Oct 24, 2023
0
34
New research from The Ohio State University College of Medicine finds COVID-19 vaccine mandates are highly effective at reducing the spread of the virus and increasing immunity in a university setting.
Sep 6, 2023
0
239
New research in the journal Nature Communications gives scientists an important window into how Ebola virus replicates inside host cells. The study, led by scientists at La Jolla Institute for Immunology (LJI), reveals the ...
Aug 9, 2023
0
46
A protein responsible for lethal liver disease in mice infected with Rift Valley fever virus (RVFV) has been identified by scientists at the University of Pittsburgh Center for Vaccine Research. These results from new research ...
Jul 26, 2023
0
44
Hepatitis C and hepatitis B viruses both attack the liver, eventually causing deadly cirrhosis or cancer. But while antivirals can cure 95% of HCV infections, its cousin HBV has long eluded effective therapeutics. As a result, ...
Apr 13, 2023
0
59
A new dengue treatment that could become the first to prevent and treat the virus has proven effective in initial trials in monkeys, according to new research.
Mar 16, 2023
0
47
More than 40 years into the HIV pandemic, scientists are still turning up clues revealing how the virus hijacks its host's cellular processes to support its own replication—and promote the long-term survival of the virus ...
A new NIST Standard Reference Material supports the accurate measurement of the amount of a common but potentially dangerous virus in patients.
Jul 20, 2022
0
53
In a case study, scientists of the German Center for Infection Research (DZIF) and the University Medical Center Hamburg-Eppendorf investigated the T-cell response of a cancer patient, who was suffering from prolonged COVID-19. ...
Jul 14, 2022
0
51
